| Literature DB >> 36237626 |
Wen-Cai Li1, Yun-Xiang Zhou2, Gang Zhu1, Kai-Liang Zeng1, Hai-Yong Zeng1, Jian-Sheng Chen1, Yi-Fan Deng1, Zhong-Zong Qin1, Hong-Hai Luo1.
Abstract
Background and purpose: Following mechanical thrombectomy (MT), patients with large artery occlusive acute ischemic stroke (LAO-AIS) often have cerebral herniation due to its complications, resulting in poor prognosis. Decompressive craniectomy (DC) can markedly improve patient prognosis. This study aimed to verify the predictive value of clinical parameters such as the systemic immune-inflammatory index (SII) for DC in patients with LAO-AIS after MT.Entities:
Keywords: decompressive craniectomy; large artery occlusive acute ischemic stroke; mechanical thrombectomy; nomogram; systemic immune-inflammation index
Year: 2022 PMID: 36237626 PMCID: PMC9551394 DOI: 10.3389/fneur.2022.945437
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1Flow chart of this study. LAO-AIS, large-arterial occlusion acute ischemic stroke; MT, mechanical thrombectomy.
Baseline table.
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
| ||||
| Age (years) | 56.9 ± 8.9 | 56.1 ± 5.6 | 56.6 ± 9.2 | 0.799 | |
| Gender ( | Male | 118 (68.2%) | 13 (7.5%) | 105 (60.7%) | 0.743 |
| Female | 55 (31.8%) | 7 (4.0%) | 48 (27.7%) | ||
| Systolic BP (mmHg) | 143.8 ± 26.3 | 137.6 ± 35.5 | 144.6 ± 24.9 | 0.268 | |
| Diastolic BP (mmHg) | 85.9 ± 16.3 | 85.7 ± 26.6 | 85.9 ± 14.5 | 0.976 | |
| Hypertension ( | Yes | 90 (52.0%) | 8 (4.6%) | 82 (47.4%) | 0.252 |
| No | 83 (48.0%) | 12 (6.9%) | 71 (41.0%) | ||
| Atrial fibrillation (n) | Yes | 38 (22.0%) | 3 (1.7%) | 35 (20.2%) | 0.424 |
| No | 135 (78.0%) | 17 (9.8%) | 118 (68.3%) | ||
| Diabetes ( | Yes | 33 (19.1%) | 4 (2.3%) | 29 (16.8%) | 0.911 |
| No | 140 (80.9%) | 16 (9.2%) | 124 (71.7%) | ||
| Hyperlipidemia ( | Yes | 48 (26.2%) | 7 (4.0%) | 37 (21.4%) | 0.296 |
| No | 135 (73.8%) | 13 (7.5%) | 116 (67.1%) | ||
| Smoke ( | Yes | 68 (39.3%) | 7 (4.0%) | 61 (35.3%) | 0.678 |
| No | 105 (60.7%) | 13 (7.5%) | 92 (53.2%) | ||
| Alcoholism ( | Yes | 25 (14.5%) | 2 (1.2%) | 23 (13.3%) | 0.547 |
| No | 148 (85.5%) | 18 (10.4%) | 130 (75.1%) | ||
| Lesion Site ( | Left | 86 (47.0%) | 11 (6.4%) | 76 (43.9%) | 0.654 |
| Right | 97 (53.0%) | 9 (5.2%) | 77 (44.5%) | ||
| Responsible Artery ( | Middle Cerebral Artery | 110 (63.6%) | 11 (6.4%) | 99 (57.2%) | 0.396 |
| Internal Carotid Artery | 63 (36.4%) | 9 (5.2%) | 54 (31.2%) | ||
Figure 2Comparison of SII between experimental group and control group. *p < 0.05.
Figure 3ROC curve of SII.
Binary logistic regression analysis predicting outcome.
|
|
|
| ||||
|---|---|---|---|---|---|---|
|
|
|
|
|
| ||
| Gender ( | 0.743 | |||||
| Male | 118 | 1 | ||||
| Female | 55 | 1.178 (0.442–3.139) | ||||
| Age (years) | 0.847 | |||||
| >55 | 83 | 1 | ||||
| ≤55 | 90 | 0.913 (0.359–2.318) | ||||
| Hypertension ( | 0.257 | |||||
| Yes | 90 | 1 | ||||
| No | 83 | 0.577 (0.223–1.492) | ||||
| Atrial fibrillation ( | 0.428 | |||||
| Yes | 38 | 1 | ||||
| No | 135 | 0.595 (0.165–2.149) | ||||
| Hyperlipidemia ( | 0.300 | |||||
| Yes | 44 | 1 | ||||
| No | 129 | 1.688 (0.627–4.546) | ||||
| Diabetes ( | 0.911 | |||||
| Yes | 33 | 1 | ||||
| No | 140 | 1.069 (0.332–3.437) | ||||
| Smoke ( | 0.675 | |||||
| Yes | 68 | 1 | ||||
| No | 105 | 0.812 (0.307–2.151) | ||||
| Alcoholism ( | 0.550 | |||||
| Yes | 25 | 1 | ||||
| No | 148 | 0.628 (0.136–2.891) | ||||
| PT (s) | 0.849 | |||||
| ≤14 | 98 | 1 | ||||
| >14 | 72 | 0.909 (0.340–2.432) | ||||
| Missing | 3 | |||||
| APTT (s) | 0.102 | |||||
| ≤37 | 111 | 1 | ||||
| >37 | 59 | 0.343 (0.095–1.236) | ||||
| Missing | 3 | |||||
| D-D (ng/ml) | 0.209 | |||||
| ≤500 | 40 | 1 | ||||
| >500 | 131 | 2.643 (0.581–12.027) | ||||
| Missing | 2 | |||||
| FIB (g/L) | 0.399 | |||||
| ≤4 | 134 | 1 | ||||
| >4 | 39 | 1.558 (0.556–4.370) | ||||
| LDL (mmol/L) | 0.917 | |||||
| ≤3.1 | 106 | 1 | ||||
| >3.1 | 55 | 1.058 (0.369–3.030) | ||||
| Missing | 12 | |||||
| K (mmol/L) | 0.044 | 0.078 | ||||
| ≥3.5 | 121 | 1 | 1 | |||
| <3.5 | 52 | 2.643 (1.026–6.804) | 2.395 (0.907–6.324) | |||
| Ca (mmol/L) | 0.155 | |||||
| ≥2.11 | 127 | 1 | ||||
| <2.11 | 46 | 2.018 (0.767–5.305) | ||||
| Triglyceride (mmol/L) | 0.055 | |||||
| >1.7 | 22 | 1 | ||||
| ≤1.7 | 131 | 2.018 (0.767–5.305) | ||||
| Missing | 20 | |||||
| Albumin (g/L) | 0.460 | |||||
| <40 | 96 | 1 | ||||
| ≥40 | 68 | 1.476 (0.525–4.149) | ||||
| Missing | 9 | |||||
| SII (× 109/L) | 0.006 | 0.010 | ||||
| >2505.7 | 125 | 1 | 1 | |||
| ≤2507.7 | 48 | 3.832 (1.474–9.963) | 3.579 (1.360–9.422) | |||
Figure 4Nomogram of clinical data.
Figure 5(A) ROC curve of training set data. (B) ROC curve of testing set data.
Figure 6(A) Calibration curve of training set data. (B) Calibration curve of testing set data.